Clinical observation of angiotensin Ⅱ receptor antagonist on the treatment of earlier period of diabetes and kidney disease
- VernacularTitle:缬沙坦治疗早期糖尿病肾病的临床观察
- Author:
Xiuhua ZHONG
;
Ping LI
;
Zhihua HUANG
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathies;
Receptors;
angiotenain
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(8):1282-1283
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the application of angiotensin Ⅱ receptor antagonist valsartan in reducing minim albuminuria in earlier period of the diabetes and kidney disease.Methotis 36 patients Who administered angiotenain Ⅱ receptor antagonist valsartan 80～160nag,qd,for 8 weeks.Compared with symptoms before the treatment,the blood pressure,the amount of the urinary albuminufia,and observed the change of the empty stomach blood sugar,the saccharified hemoglobin,the triglyceride,the total cholesterol,the endogenous creatinine clearance rate,etc.Results After the treatment,the urinary albumin drops obviously(P＜0.01),While the blood pressure,the empty stomach blood sugar,the saccharified hemoglobin,the triglyceride,the total cholesterol and the endogenous creatinine clearance rate have no obvious change.There is no obvious side effect during therapeutic process.Conclusion The application of angiotenain Ⅱ receptor antagonist valsartan can reduce the amount of the urinary albumin,is the effective way in treating the earlier period of the diabetes and kidney disease.
